日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma

肾细胞癌中三级淋巴结构和耗竭的组织驻留T细胞的存在决定了PD-1阻断疗法的临床疗效

Miya B Hugaboom #,Lena V Wirth #,Kelly Street #,Neil Ruthen #,Opeyemi A Jegede,Nicholas R Schindler,Valisha Shah,Jacob P Zaemes,Nourhan El Ahmar,Sayed Matar,Varunika Savla,Toni K Choueiri,Thomas Denize,Destiny J West,David F McDermott,Elizabeth R Plimack,Jeffrey A Sosman,Naomi B Haas,Mark N Stein,Robert Alter,Mehmet A Bilen,Michael E Hurwitz,Hans Hammers,Sabina Signoretti,Michael B Atkins #,Catherine J Wu #,David A Braun #

The SLC1A1/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs

SLC1A1/EAAT3二羧酸氨基酸转运蛋白是一种表观遗传失调的营养载体,它维持着致癌代谢程序。

Treg Grubb ,Pooneh Koochaki ,Sayed Matar ,Fatme Ghandour ,Marc Machaalani ,Eddy Saad ,Cerise Tang ,Eduard Reznik ,Jesminara Khatun ,Carleigh Salem ,Noah Dubasik ,David A Orlando ,Matthew G Guenther ,Gyanu Parajuli ,Raghvendra M Srivastava ,Steven R Martinez ,Jesse A Coker ,Ritesh R Kotecha ,A Ari Hakimi ,John M Asara ,Timothy A Chan ,Sakari Vanharanta ,Shaun R Stauffer ,William G Kaelin Jr ,Sabina Signoretti ,Toni K Choueiri ,Abhishek A Chakraborty

PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti-PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients

肿瘤内调节性 T 细胞上的 PD-1 表达与转移性透明细胞肾细胞癌患者无法从抗 PD-1 疗法获益有关

Thomas Denize, Opeyemi A Jegede, Sayed Matar, Nourhan El Ahmar, Destiny J West, Emily Walton, Aseman Sheshdeh Bagheri, Varunika Savla, Yasmin Nabil Laimon, Saurabh Gupta, Sai Vikram Vemula, David A Braun, Kelly P Burke, Paul J Catalano, Gordon J Freeman, Robert J Motzer, Michael B Atkins, David F Mc